The immune system affords protection from environmental pathogens, but this service comes at a price: uncontrolled responses can damage the host by causing immune pathology, and responses to self-antigens can result in autoimmunity.T reg cells are therefore essential for a balanced immune system. The forkhead--winged helix transcription factor Foxp3 coordinates the T reg cell gene expression program, and its absence causes death by lymphoproliferation and multiorgan autoimmunity in humans with immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome and in Foxp3-deficient mice ([@bib3]; [@bib15]; [@bib21]).

Intrathymically induced T reg (itTreg) cells are thought to arise by a two-step process, in which TCR signaling induces competence for Foxp3 expression and the expression of the high-affinity IL-2 receptor-α chain (CD25). IL-2, or other cytokines that activate STAT5, then induce Foxp3 expression ([@bib6]; [@bib27]; [@bib42]). The contributions of TGF-β to itTreg cell differentiation ([@bib29]) and to the maintenance of functional T reg cells in peripheral lymphoid organs ([@bib31]; [@bib26]; [@bib34]) remain to be fully elucidated. Runx transcription factors are involved in the induction and in the maintenance of Foxp3 expression ([@bib5]; [@bib23]; [@bib24]; [@bib38]), and microRNAs contribute to both the development ([@bib9]) and the maintenance of T reg cells ([@bib8]; [@bib28]; [@bib45]).

Extrathymically induced T reg (etTreg) cells can be formed in peripheral lymphoid organs ([@bib1]; [@bib25]; [@bib11]). Although the physiological importance of etTreg cells is much less certain than that of itTreg cells, etTreg cells have been intensely studied because they can easily be generated in vitro and bear therapeutic promise. Major inducers of Foxp3 expression in peripheral T cells in vitro include TCR signaling in the presence of TGF-β ([@bib7]), the downstream TGF-β signal transducers Smad2 and Smad3, and retinoic acid ([@bib2]; [@bib10]; [@bib32]; [@bib40]). Genetic and pharmacological evidence indicates that the PI3K--Akt--mTOR signaling network interferes with Foxp3 induction in vitro, as well as in vivo ([@bib17]; [@bib39]; unpublished data), but the mechanisms that link PI3K--Akt--mTOR signaling to Foxp3 expression have until recently been unknown.

Conserved noncoding sequences integrate signals influencing Foxp3 expression
============================================================================

Like other metazoan genes, the expression of *Foxp3* is regulated by multiple transcription factors, by chromatin, and by cis-regulatory elements. TCR activation induces the binding of transcription factors such as NFAT, AP1, CREB, and ATF to the *Foxp3* promoter and enhancer elements ([@bib22]; [@bib41]). T reg cell development is impaired in T cells lacking signaling molecules needed for NF-κB activation (e.g., PKC-θ, Bcl10, CARMA1, and MALT1), and c-Rel is a critical NF-κB component in this context ([@bib20]; [@bib30]; [@bib37]; [@bib44]).

In addition to the promoter, at least three conserved noncoding sequence (CNS) elements contribute to the regulation of the *Foxp3* locus ([@bib22]; [@bib41]; [@bib19]; [@bib44]). Because the nomenclatures used in these studies differ, we will refer to these elements by their position relative to the *Foxp3* transcription start site (TSS; [Fig. 1](#fig1){ref-type="fig"}). Two CNS +2 kb and +4.5 kb in the 5′ untranslated region (referred to as CNS2 and 3 in [@bib41] and [@bib22], and as CNS1 and 2 in [@bib44]). A further CNS is at +7 kb, just downstream of the first coding exon (CNS3 in [@bib44]). The CNS at +7 kb plays a role in itTreg and etTreg cells, as its deletion reduces the frequency of T reg cells generated in the thymus and in the periphery ([@bib44]). In contrast, the CNS at +2 kb is not required for itTreg cell differentiation. Consistent with a role in inducible Foxp3 expression ([@bib44]), this CNS contains binding sites for NFAT, an effector of TCR signaling, and for SMAD proteins, which mediate TGF-β signaling ([@bib22]; [@bib41]; [@bib44]). Finally, the CNS at +4.5 kb is important for the maintenance, rather than the induction, of Foxp3 expression ([@bib44]). This CNS contains a region rich in CpG dinucleotides, the targets for mammalian DNA methylation, and is methylated in conventional T cells and demethylated in itTreg cells. Demethylation of this region by inhibition or genetic deletion of methyltransferase enzymes leads to stable Foxp3 expression ([@bib19]). Loss of DNA methylation promotes the binding to the CNS at +4.5 kb of the transcription factors CREB, ATF ([@bib22]), the NF-kB component c-Rel ([@bib30]), Runx--Cbfb ([@bib5]; [@bib38]), and, interestingly, Foxp3 itself. Hence, the CNS at +4.5 kb could form part of a positive feedback loop, by which Foxp3 maintains its own expression ([@bib44]).

![**Signals, factors, and regulatory elements that control Foxp3 expression.** The figure shows the 5′ part of the mouse *Foxp3* locus, as well as signals and factors known to regulate its expression. Conservation is indicated in blue as a track from the University of California Santa Cruz Genome Browser (<http://genome.ucsc.edu>; [@bib36]). Conserved noncoding sequences with known functions are indicated in red. Black rectangles indicate exons (open for noncoding, filled for coding). TSS indicates the transcription start site.](JEM_20101156_RGB_Fig1){#fig1}

Foxos link PI3K--Akt--mTOR to Foxp3
===================================

Efficient Foxp3 induction requires proteins that limit PI3K activity, such as Cbl-b ([@bib43]) and PTEN ([@bib39]). Conversely, constitutive Akt activity interferes with Foxp3 induction ([@bib17]). mTORC2 activates Akt by phosphorylating it on Ser473, and loss or inhibition of mTORC2 inactivates Akt and consequently promotes Foxp3 induction ([@bib13]). Harada et al. (this issue) and [@bib33] now align Foxo1 and Foxo3a in the signaling pathway connecting PI3K--Akt--mTOR to Foxp3.

In agreement with previous work ([@bib43]), [@bib16] found that Cbl-b--deficient CD4 T cells expressed less Foxp3 in response to TGF-β in vitro and in an adoptive transfer model in vivo. Cbl-b deficiency was thought to impair cellular responses to TGF-β by affecting Smad2 phosphorylation ([@bib43]). Surprisingly, [@bib16] found intact TGF-β responses in Cbl-b--deficient CD4 T cells. Instead, they analyzed Foxo transcription factors, which have important functions in the homeostasis of the immune system ([@bib18]). The activity of Foxo proteins is regulated at multiple levels, most strikingly by Akt-mediated phosphorylation. Phosphorylation by Akt inactivates Foxo proteins by excluding them from the nucleus. In this way, Foxo localization reflects PI3K signaling ([@bib18]). The link to Cbl-b is previous work showing that Cbl-b promotes ubiquitinylation of p85, the regulatory subunit of PI3K, and thereby affects the activity of Akt ([@bib14]). Consistent with increased PI3K--Akt signaling in Cbl-b--deficient T cells, [@bib16] noted increased phosphorylation of Foxo3a in Cbl-b--deficient CD4 T cells. Foxo3a-deficient CD4 T cells showed reduced Foxp3 induction in response to TGF-β. In contrast, deletion of Foxo3a did not have any effect on the numbers of Foxp3-expressing itTreg cells ([@bib16]), suggesting a preferential involvement of Foxo3a in etTreg cell, as opposed to itTreg cell differentiation. This is consistent with observations showing that the increased PI3K signaling that results from the loss of Cbl-b impaired inducible Foxp3 expression, but did not substantially impact itTreg cell numbers ([@bib43]). However, both inducible and itTreg differentiation were affected by constitutively active Akt ([@bib17]).

[@bib33] demonstrate that the apparently selective requirement of Foxo3a for Foxp3 induction in etTreg cells is caused, at least in part, by redundancy between Foxo3a and Foxo1. Consistent with the finding that the loss of Foxo3a alone did not affect itTreg cell development ([@bib16]), [@bib33] found that even a single allele of *Foxo1* (*Foxo1*^+/−^*Foxo3a*^−/−^) or *Foxo3a* (*Foxo1*^−/−^*Foxo3a*^+/−^) was sufficient for normal numbers of itTreg and etTreg cells. In contrast, complete loss of Foxo1 and Foxo3a in the T cell lineage abrogated inducible Foxp3 expression. *Foxo1*^−/−^*Foxo3a*^−/−^ CD4 T cells and thymocytes failed to up-regulate Foxp3 expression not only in response to activation in the presence of TGF-β, but also when subjected to 18 h of TCR signaling followed by the removal of TCR signal, an in vitro protocol that may be more akin to in vivo generation of etTreg cells ([@bib25]; [@bib35]). This treatment results in a loss of PI3K--Akt--mTOR activity and the de novo expression of Foxp3 in wild-type cells ([@bib39]).

Importantly, [@bib33] found that T cell--specific deletion of Foxo1 and Foxo3a also led to lower numbers of thymic and peripheral T reg cells at 3 wk of age. This numerical deficit disappeared by 6 wk of age, but the T reg cells that were generated were not normal. *Foxo1*^−/−^*Foxo3a*^−/−^ T reg cells produced inflammatory cytokines (interferon-γ and IL-17) after activation and showed impaired regulatory function in vitro and in vivo. *Foxo1*^−/−^*Foxo3a*^−/−^ splenic T reg cells showed normal expression of Foxp3, but many T reg signature genes were deregulated ([@bib33]). It remains to be seen whether these genes are directly regulated by Foxo factors, or if their expression is affected by the increased proliferation of Foxo1^−/−^Foxo3a^−/−^ T reg cells ([@bib33]).

[@bib16] identified Foxo binding motifs in the *Foxp3* promoter region and used chromatin immunoprecipitation (ChIP) assays to demonstrate the binding of Foxo proteins to the *Foxp3* promoter. [@bib33] found several conserved Foxo consensus sequences in the *Foxp3* locus, and their ChIP experiments indicate binding to the promoter and to the CNS region at +4.5 kb (referred to as CNS3 in their paper) in T reg cells, but not in conventional T cells. Reporter gene assays indicate the functional importance of a site close to the *Foxp3* transcription start site ([@bib16]; [@bib33]). In light of these data, which suggest a role for Foxo proteins in the regulation of Foxp3, it is puzzling that Foxp3 expression was apparently normal in *Foxo1*^−/−^*Foxo3a*^−/−^ splenic T reg cells ([@bib33]).

Conclusions
===========

The emerging scenario is that PI3K--Akt--mTOR signaling prevents the induction, but does not interfere with the maintenance, of Foxp3 expression via Foxo factors. It is therefore likely that with Foxo1 and Foxo3a, [@bib16] and [@bib33] have identified a molecular link between PI3K--Akt--mTOR signaling and Foxp3 induction. Time will tell if there are other negative regulators of Foxp3 expression downstream of PI3K--Akt--mTOR signaling.

Given the promise of inducible Foxp3 expression in the immunotherapy of autoimmunity and immune pathology ([@bib12]), Foxo factors, especially the kinases that control their activity, represent potential drug targets ([@bib4]).
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